A decade ago, very few people knew what hemp-derived cannabidiol was, better known as CBD. However, in a few years, the CBD market is forecast to hit $22 billion, according to cannabis industry analysts. Right now, the industry is on track to hit $591 million which could grow even higher because of several factors.
People young and old, around the globe, take CBD in pill form, swallow a spoonful of CBD oil, or even rub CBD-infused creams onto themselves in hopes of relief from numerous ailments. Recently, CBD products have expanded into natural food stores, doctors’ offices, cafes, and even Big Pharma is progressively developing more and more cannabis-based drugs.
The United States 2018 Farm Bill, which if passed, includes the Hemp Farming Act of 2018 that will remove hemp as a designated as controlled substance, legalizing the crop under federal law. This will permit CBD to be sold legally throughout the entire country, which presently laws vary from state to state. As the world continues to see the potential of CBD products, here are a few CBD-friendly marijuana stocks to consider planting in your portfolio.
Canadian-based Integrated Cannabis develops, manufactures, and distributes botanically-based consumable products domestically as well as internationally. The company offers eight novel nutraceutical sprays which target pain relief, sleep, libido, recovery and more with four infused with hemp-based CBD under the X-SPRAYS brand. It also has a market ready Tetrahydrocannabinol (THC)-infused spray product as well as the required licensing for manufacturing and intends to launch sales in Q4.
A Letter of Intent was recently completed to distribute X-SPRAYS™ products throughout the clinics and doctors’ offices of Empower Clinics Inc. CSE (EPW), a lead operator of medical marijuana and wellness clinics in the U.S. Today, the company annouced an agreement to collaborate on X-SPRAYSTM products for the Canadian market with GTEC Holdings Ltd (GTEC) (GGTTF), a Canadian License Producer under Health Canada’s ACMPR. The agreement entails co-development and marketing of innovative spray products containing Cannabidiol (CBD) and/or Tetrahydrocannabinol (THC) for the Canadian medicinal and recreational markets.
India Globalization (IGC)
India develops and commercializes cannabis-based therapies to treat Alzheimer’s, pain, nausea, eating disorders, Parkinson’s, and epilepsy in humans as well as dogs and cats. The company operates through two segments, Legacy Infrastructure and Medical Cannabis Based Alternative Therapies (MCBAT). The MCBAT segment offers IGC-501 neuropathic pain, Serosapse for Parkinson’s, Caesafin for seizures in cats and dogs, and Natrinol for indications of cancer and AIDS as well as Hyalolex for Alzheimer’s.
The company announced yesterday that it has executed a distribution and partnership agreement for several products including a sugar free, energy drink called ‘Nitro G’. IGC intends on creating a branded, hemp/CBD-infused version of the formulation. The company will pay 797,000 shares of restricted, unregistered, common stock, for a 10-year agreement, with an option for multiple 5-year extensions, for the rights to market the products in the U.S., Canada, Mexico and South America and exclusive global rights to all developed CBD-infused products.
Aurora, one of largest marijuana companies, is vertically integrated and horizontally diversified from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution. The company has recreational marijuana supply agreements with several provinces throughout Canada and has completed fifteen acquisitions and strategic partnerships.
The company released fiscal fourth-quarter earnings earlier this week and confirmed its intention to list stock on the Nasdaq or the New York Stock Exchange. Recent news has circulated that Coca-Cola Co. (KO) is in talks with Aurora to make marijuana-infused beverages to ease inflammation and pain. Aurora currently offers three CBD products for retail.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Integrated Cannabis Company, Midam is being paid $25,000 per month for a period of 6 months beginning September 4, 2018, and ending March 9, 2019. We own ZERO shares of Integrated Cannabis Company. We may buy or sell additional shares of (ICNAF)/(ICAN) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Integrated Cannabis Company.